V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003754 | 310010361 | 1.73 | 97.7 | Palliative (P) | 2014-10-29 | 2014-10-29 | EOX | null | N | 310018584 | VEMURAFENIB |
| 310003755 | 310010361 | null | 62.7 | Palliative (P) | 2014-11-17 | 2014-11-18 | Imatinib 600mg | null | null | 310018584 | VEMURAFENIB |
| 310003756 | 310010361 | 1.62 | null | Palliative (P) | 2013-10-27 | 2013-10-28 | CISPLATIN + FLUOROURACIL | N | N | 310018584 | IMATINIB |
| 310003760 | 310001571 | 1.52 | 65 | Curative (C) | 2017-12-29 | 2018-01-01 | CAPECITABINE + OXALIPLATIN | 2 | N | 310018592 | BCG |
| 310003761 | 310006689 | 1.64 | 64 | Disease modification (D) | 2010-03-05 | 2014-11-23 | Vemurafenib | 2 | N | 310018594 | HYDROXYCARBAMIDE |
| 310003762 | 310009105 | null | 70 | Palliative (P) | 2017-08-23 | 2017-08-31 | ECX | N | N | 310018597 | ECX |
| 310003763 | 310009105 | 1.68 | 74.7 | Disease modification (D) | 2015-11-08 | 2015-11-12 | CAPECITABINE + OXALIPLATIN | N | N | 310018597 | GEMCITABINE + PACLITAXEL |
| 310003764 | 310009105 | null | 54.4 | Palliative (P) | 2017-08-14 | 2017-09-05 | ECX | 99 | N | 310018597 | CAPECITABINE |
| 310003765 | 310009105 | 1.61 | 68.3 | Disease modification (D) | 2015-09-16 | 2015-09-16 | Imatinib 400mg | 02 | N | 310018597 | CISPLATIN + ETOPOSIDE |
| 310003766 | 310011796 | 1.82 | 76.2 | Palliative (P) | 2016-02-24 | 2016-02-28 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310018602 | GEMCITABINE |
| 310003767 | 310011667 | 1.63 | 89.3 | Palliative (P) | 2013-08-29 | 2013-09-02 | Liposomal Doxorubicin 40mg/m2 | N | N | 310018603 | CAPECITABINE + CISPLATIN |
| 310003768 | 310001572 | 1.62 | null | Adjuvant (A) | 2015-11-25 | 2015-11-29 | EOX | N | N | 310018604 | EOX |
| 310003769 | 310001573 | null | null | Palliative (P) | 2014-07-01 | 2014-07-01 | GEM-P | N | null | 310018605 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003770 | 310001573 | 1.74 | 93.4 | Curative (C) | 2017-06-29 | 2017-06-30 | GEM-P | null | null | 310018605 | CAPECITABINE + CISPLATIN |
| 310003771 | 310001574 | 1.81 | 98 | Curative (C) | 2017-10-19 | 2017-10-19 | CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | N | N | 310018607 | NOT MATCHED |
| 310003772 | 310001575 | null | 55.4 | Adjuvant (A) | 2015-08-17 | 2015-08-18 | Rituximab | N | N | 310018609 | DACARBAZINE |
| 310003773 | 310001575 | 1.93 | 100.7 | null | 2016-03-31 | 2016-04-01 | ICON8 TRIAL | N | N | 310018609 | LIPOSOMAL DOXORUBICIN |
| 310003774 | 310001576 | 1.62 | 65.9 | Curative (C) | 2013-07-09 | 2013-07-12 | CHOEP - 21 days | 2 | N | 310018612 | CHOEP |
| 310003775 | 310006692 | 1.63 | 105.2 | Adjuvant (A) | 2016-09-16 | 2016-09-27 | null | 2 | N | 310018613 | NOT MATCHED |
| 310003776 | 310001577 | 1.75 | 74.4 | Palliative (P) | null | 2017-11-11 | ICON8 TRIAL | N | N | 310018615 | LIPOSOMAL DOXORUBICIN |
| 310003777 | 310001577 | 0 | 72.4 | Palliative (P) | 2016-07-31 | 2016-08-10 | Dacarbazine | N | N | 310018615 | CISPLATIN + FLUOROURACIL |
| 310003778 | 310001578 | 1.6 | 58 | Neo-adjuvant (N) | 2013-09-01 | 2013-09-04 | Bevacizumab+Carbo+Pacliaxel | N | N | 310018619 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003779 | 310001579 | 1.79 | 95.4 | Palliative (P) | 2014-04-22 | 2014-05-23 | Liposomal Doxorubicin 40mg/m2 | N | N | 310018620 | MITOMYCIN INTRAVESICULAR |
| 310003780 | 310001579 | null | null | Palliative (P) | null | 2016-10-05 | Imatinib 400mg | null | null | 310018620 | GEMCITABINE + PACLITAXEL |
| 310003781 | 310001580 | 1.64 | 50 | null | null | 2015-01-17 | CHOEP - 21 days | N | N | 310018623 | CHOEP |
| 310003782 | 310001580 | 1.54 | 63 | Palliative (P) | 2015-08-05 | 2015-08-17 | Liposomal Doxorubicin (20mg/m2) | N | N | 310018623 | BEXAROTENE |
| 310003783 | 310001580 | 1.8 | 61 | Palliative (P) | 2016-04-28 | 2016-06-08 | Vemurafenib | N | N | 310018623 | OXALIPLATIN + MDG |
| 310003784 | 310001581 | 1.66 | 80 | Palliative (P) | 2015-04-23 | 2015-04-23 | Vemurafenib | N | N | 310018630 | CISPLATIN + FLUOROURACIL |
| 310003785 | 310001581 | 1.67 | 56.4 | Disease modification (D) | 2017-01-13 | 2017-09-18 | Mitomycin Intravesical | 02 | N | 310018630 | DACARBAZINE |
| 310003786 | 310001581 | 1.63 | 60.2 | Neo-adjuvant (N) | 2017-08-12 | 2017-08-19 | Paclitaxel 7 day | N | N | 310018630 | PACLITAXEL |
| 310003787 | 310001581 | null | 58.4 | null | null | 2014-06-10 | Imatinib 400mg | Y | null | 310018630 | CISPLATIN + FLUOROURACIL |
| 310003788 | 310001582 | 1.6 | 59 | Palliative (P) | 2015-03-15 | 2015-03-17 | Bevacizumab+Carbo+Pacliaxel | N | N | 310018637 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003789 | 310001583 | 1.57 | null | Palliative (P) | 2018-04-19 | 2018-05-10 | IPILIMUMAB + NIVOLUMAB | 02 | N | 310018640 | IPILIMUMAB + NIVOLUMAB |
| 310003795 | 310001587 | null | 71.4 | Curative (C) | 2013-10-11 | 2013-10-19 | CHOEP - 21 days | 02 | N | 310018648 | CHOEP |
| 310003796 | 310006699 | 1.67 | 58 | Palliative (P) | 2017-11-07 | 2017-11-29 | ECX | N | N | 310018649 | ECX |
| 310003797 | 310001588 | 1.73 | 79.7 | Neo-adjuvant (N) | 2017-09-11 | 2017-09-17 | Bevacizumab+Carbo+Pacliaxel | N | N | 310018650 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003798 | 310001589 | 1.72 | null | Palliative (P) | 2015-09-23 | 2015-09-23 | ECX | null | null | 310018651 | ECX |
| 310003799 | 310006700 | 1.73 | 58.2 | null | 2016-02-10 | 2016-03-06 | Liposomal Doxorubicin (Caelyx) | null | null | 310018653 | MITOMYCIN INTRAVESICULAR |
| 310003800 | 310006700 | null | 98.4 | Curative (C) | 2013-05-04 | 2013-05-05 | Cisplatin +Fluorouracil (2 wk) | 02 | N | 310018653 | ICON TRIAL |
| 310003802 | 310001591 | null | null | Palliative (P) | 2016-05-16 | 2016-05-17 | IPILIMUMAB + NIVOLUMAB | N | N | 310018662 | IPILIMUMAB + NIVOLUMAB |
| 310003803 | 310001592 | 0 | 74 | Curative (C) | 2016-12-26 | 2016-12-29 | CHOEP - 21 days | 02 | N | 310018667 | BCG |
| 310003804 | 310006701 | 1.93 | 70 | Radical (R) | 2014-10-01 | 2014-10-04 | CHOEP - 14 days | null | null | 310018668 | CHOEP |
| 310003805 | 310001593 | 1.51 | 63 | Palliative (P) | null | 2015-03-14 | ECX | Y | N | 310018671 | CAPECITABINE |
| 310003806 | 310001593 | 0 | 89.7 | Not known (9) | 2014-10-20 | 2014-11-04 | Gemcitabine weekly | N | N | 310018671 | GEMCITABINE |
| 310003807 | 310001594 | null | null | null | 2015-06-27 | 2015-06-29 | CHOEP | N | N | 310018675 | CHOEP |
| 310003808 | 310001595 | 1.68 | 45.2 | Palliative (P) | 2015-03-31 | 2015-03-31 | IPILIMUMAB + NIVOLUMAB | N | N | 310018676 | IPILIMUMAB + NIVOLUMAB |
| 310003809 | 310001596 | 1.64 | 69.7 | Palliative (P) | 2015-06-13 | 2015-06-22 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018678 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003810 | 310001597 | 1.68 | 79.8 | Palliative (P) | 2016-11-27 | 2016-12-08 | ECX | 02 | N | 310018680 | CISPLATIN + FLUOROURACIL |
| 310003811 | 310001598 | 1.81 | null | null | null | 2016-07-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 310018681 | IMATINIB |
| 310003812 | 310001599 | 1.19 | 69.7 | Curative (C) | 2015-01-15 | 2015-01-22 | Retinoblastoma Rel | 2 | N | 310018683 | NOT MATCHED |